CTOs on the Move

Edwards Lifesciences

www.edwards.com

 
Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. Headquartered in Irvine, California, Edwards Lifesciences has extensive operations in North America, Europe, Japan, Latin America and Asia and currently employs 11,000+ individuals worldwide. For us, helping patients is not a slogan ¬ it`s our life¹s work. From developing devices that replace or repair a diseased heart valve to creating new ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Kapil Assudani
 Global Head Cyber Security Profile

Similar Companies

Astellas Gene Therapies

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.

Berchtold Corp

Berchtold Corp is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Co-View Capital

Co-View Capital is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ophthonix

Ophthonix is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lumitron Technologies

Based in California, Lumitron Technologies Inc. was established to develop and commercialize unique x­‐ray systems that enable revolutionary new capabilities for ultrahigh­‐fidelity imaging, ultra­‐low dose radiography, hyper­‐precision radiotherapy, as well as element-specific and isotope-specific material identification, assay and imaging.